Floatz logo

Dotarem

Liver Cirrhosis

Massachusetts General HospitalActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
73/ 100

Competitive context

48 Active assets in the Liver Cirrhosis cohort.

Asset / SponsorPhaseRating
SIMVASTATIN
Chang Gung Memorial Hospital
Phase 4BBB
Rifaximin
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4BBB
WARFARIN
Kafrelsheikh University
Phase 4BB
Entecavir
Third Affiliated Hospital, Sun Yat-Sen University
Phase 4BB
Thymosin-̑
Beijing Friendship Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Dotarem is also rated in:

early-onset autosomal dominant Alzheimer diseaseDormant
CC
Indicative ·
41 / 100
View asset →
Hepatic Cell CarcinomaDormant
D
Indicative ·
30 / 100
View asset →
Portal HypertensionDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →